Authors:
Furlong, T
Storb, R
Anasetti, C
Appelbaum, FR
Deeg, HJ
Doney, K
Martin, P
Sullivan, K
Witherspoon, R
Nash, RA
Citation: T. Furlong et al., Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acutegraft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities, BONE MAR TR, 26(9), 2000, pp. 985-991